Drug intelligence / Profile preview

Diallyl Trisulfide

Development stage
Preclinical
Modality
Small Molecules
Administration
Intravenous
01

Overview

Diallyl Trisulfide (DATS) is a small molecule phytochemical derived from garlic (Allium sativum L.). It functions as a hydrogen sulfide (H2S) donor and exhibits a range of therapeutic potentials, including antioxidant, anti-inflammatory, and anti-ferroptotic effects. DATS has been shown to suppress tumor-associated macrophage M2-like polarization and recruitment by blocking the CCL5/STAT3 signaling pathway, and it inhibits alcohol dehydrogenase I (ADH1) through a mechanism involving subunits separation. It is currently under investigation for its potential in treating conditions such as hepatic ischemia-reperfusion injury and lung cancer.

Other names
AllitridinALLYL TRISULFIDEALLYLTRISULPHIDEDIALLYL TRISULPHIDE3-diallyltrisulfaneDiallyl pertrisulfide1,3-DiallyltrisulfaneDiallyl Trisulfide (AS)Trisulfide di-2-propenylDiprop-2-en-1-yltrisulfaneDiprop2-en-1-yltrisulfaneDiprop 2-en-1-yltrisulfaneAlltride
02

Targets

GSDMD (Gasdermin D)CYP2E1STAT3 (Signal Transducer and Activator of Transcription 3)CD274 (Programmed cell death protein 1 ligand 1)

Beyond the preview

Go deeper on Diallyl Trisulfide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diallyl Trisulfide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call